Stocks
Agios Pharmaceuticals (AGIO) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 3 376% | 2 465% | 4 476% | 5 735% | 28 919% | 30 632% | |||
| Changes by years, y/y, % | -1 510pp | -911pp | +2 011pp | +1 259pp | +23 185pp | +42.7% | |||
Agios Pharmaceuticals. R&D/CAPEX, %
Agios Pharmaceuticals. R&D/CAPEX, changes, pp
Agios Pharmaceuticals (AGIO) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 458.0% | 32 515% | 47 711% | 47 980% | 17 292% | 30 632% | ||
| Changes by years, y/y, % | -170 505pp | -29 695pp | +30 843pp | -2 248 520pp | +16 834pp | |||
| Changes by quarters, q/q, % | -2 296 042pp | +32 057pp | +15 195pp | +269pp | -30 687pp | |||
